$315.000,00
10% de descuento pagando con Transferencia
Ver más detalles
Descripcion
Indice
Autores
Muestra
Ficha Técnica
Descripción

Tumour-Targeting with Stimuli Responsive Vesicular Nanocarriers: Basics to Emerging Applications not only acquaints scientists and science interns with the fundamental knowledge of the experimental aspects and state-of-the-art technology for vesicular carriers to equip their rational application in tumor targeting, but also provides a holistic understanding of regulatory concerns, patents, and clinical trials. In 15 chapters. this book provides basics and advances in stimuli-responsive vesicular carriers for tumor targeting based on findings outlined in highly organized tables, illustrative figures, and flow charts.

With a focus on the extrapolation of bioengineering tools in the domain of vesicular carriers, stimuli-responsive features concerning tumors, drug delivery approaches, and associated challenges, it helps readers to define the major gaps in knowledge that can lead to significant scientific discoveries in therapy, diagnosis, and theragnosis of cancer.

  • Addresses the unmet needs and challenges confronted by nanotechnologists to foster collaboration of biologists, chemists, physicists, bioengineers, and clinicians
  • Provides an explicit account of vital aspects of PEGylation of these carriers and challenges for effective tumor targeting
  • Presents a need-of-hour discussion over regulatory concerns, clinical trials, and patents

1. Title of Book - p. i 2. Cover image - p. i 3. Title page - p. ii 4. Table of Contents - p. iii 5. Copyright - p. iv 6. List of contributors - p. ix 7. Chapter 1. Anomalous tumor microenvironment: exploitable features for drug delivery - p. 1 8. Chapter 2. Vesicular carriers for stimuli-responsive drug delivery to tumors: design considerations - p. 29 9. Chapter 3. Role of dePEGylation in vesicular carriers-mediated stimuli-responsive drug delivery to tumors - p. 65 10. Chapter 4. pH-responsive vesicular carriers as promising tools for tumor targeting - p. 91 11. Chapter 5. Enzyme-responsive vesicular carriers as an emerging approach for tumor targeting - p. 111 12. Chapter 6. Redox-responsive vesicular carriers for potential tumor-targeting applications - p. 137 13. Chapter 7. Hypoxia-responsive vesicular carriers for enhanced tumor targeting - p. 169 14. Chapter 8. Magnetically responsive and thermo-responsive vesicular carriers for improved drug delivery to tumors - p. 199 15. Chapter 9. Cancer therapy with vesicular drug delivery system and ultrasound assistance - p. 227 16. Chapter 10. Light-triggered vesicular carriers for tumor targeting - p. 259 17. Chapter 11. Electro- and mechano-responsive vesicular carriers targeting tumors - p. 283 18. Chapter 12. Emerging applications of stimuli-responsive novel vesicular carriers: exosomes, supramolecular vesicles, and catanionic vesicles - p. 317 19. Chapter 13. Vesicular carriers with multipronged features for diagnostics and theranostics - p. 341 20. Chapter 14. Nanotoxicity and challenges in stimuli-responsive vesicular carriers targeting tumor - p. 373 21. Chapter 15. Patents, clinical trials, and regulatory concerns with stimuli-responsive vesicular carriers - p. 409 22. Index - p. 427

Descripcion
Descripción

Tumour-Targeting with Stimuli Responsive Vesicular Nanocarriers: Basics to Emerging Applications not only acquaints scientists and science interns with the fundamental knowledge of the experimental aspects and state-of-the-art technology for vesicular carriers to equip their rational application in tumor targeting, but also provides a holistic understanding of regulatory concerns, patents, and clinical trials. In 15 chapters. this book provides basics and advances in stimuli-responsive vesicular carriers for tumor targeting based on findings outlined in highly organized tables, illustrative figures, and flow charts.

With a focus on the extrapolation of bioengineering tools in the domain of vesicular carriers, stimuli-responsive features concerning tumors, drug delivery approaches, and associated challenges, it helps readers to define the major gaps in knowledge that can lead to significant scientific discoveries in therapy, diagnosis, and theragnosis of cancer.

  • Addresses the unmet needs and challenges confronted by nanotechnologists to foster collaboration of biologists, chemists, physicists, bioengineers, and clinicians
  • Provides an explicit account of vital aspects of PEGylation of these carriers and challenges for effective tumor targeting
  • Presents a need-of-hour discussion over regulatory concerns, clinical trials, and patents

1. Title of Book - p. i 2. Cover image - p. i 3. Title page - p. ii 4. Table of Contents - p. iii 5. Copyright - p. iv 6. List of contributors - p. ix 7. Chapter 1. Anomalous tumor microenvironment: exploitable features for drug delivery - p. 1 8. Chapter 2. Vesicular carriers for stimuli-responsive drug delivery to tumors: design considerations - p. 29 9. Chapter 3. Role of dePEGylation in vesicular carriers-mediated stimuli-responsive drug delivery to tumors - p. 65 10. Chapter 4. pH-responsive vesicular carriers as promising tools for tumor targeting - p. 91 11. Chapter 5. Enzyme-responsive vesicular carriers as an emerging approach for tumor targeting - p. 111 12. Chapter 6. Redox-responsive vesicular carriers for potential tumor-targeting applications - p. 137 13. Chapter 7. Hypoxia-responsive vesicular carriers for enhanced tumor targeting - p. 169 14. Chapter 8. Magnetically responsive and thermo-responsive vesicular carriers for improved drug delivery to tumors - p. 199 15. Chapter 9. Cancer therapy with vesicular drug delivery system and ultrasound assistance - p. 227 16. Chapter 10. Light-triggered vesicular carriers for tumor targeting - p. 259 17. Chapter 11. Electro- and mechano-responsive vesicular carriers targeting tumors - p. 283 18. Chapter 12. Emerging applications of stimuli-responsive novel vesicular carriers: exosomes, supramolecular vesicles, and catanionic vesicles - p. 317 19. Chapter 13. Vesicular carriers with multipronged features for diagnostics and theranostics - p. 341 20. Chapter 14. Nanotoxicity and challenges in stimuli-responsive vesicular carriers targeting tumor - p. 373 21. Chapter 15. Patents, clinical trials, and regulatory concerns with stimuli-responsive vesicular carriers - p. 409 22. Index - p. 427

Indice
Autores
Muestra
Ficha Técnica